Editorial · 30 May 2025
Conference abstractPublished 14 Dec 2017
iPS-derived cardiomyocytes and keratinocytes for drug screening and cytotoxicity assays
Pluricell Biotech, Brazil
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Induced pluripotent stem cells (iPSC) are promising tool for disease modeling, regenerative medicine and drug screening. Pluricell Biotech is a Brazilian startup that develops in vitro iPS-derived models. Currently, we have established a highly efficient 2D differentiation protocol to obtain iPSC-derived cardiomyocytes. After 30 days of differentiation, PluriCardio can be replated in 2D monolayers or 3D spheroids. More than 70% of our differentiations have 95% or more of purity seen through positive expression of cardiac specific markers. Different cardiomyocytes subtypes are observed depending on how cells are plated, when in monolayer, 75% of the cells have a ventricular phenotype after 15 days of culture, and 97% have ventricular phenotype in 3D plating. We show electrophysiological response to classical drugs as expected, we checked responses to beta-adrenergic, calcium, sodium, potassium receptors including the verification of the well know hERG/IK potassium receptor. These cardiomyocytes were also used the evaluate doxorrubicin toxicity, we show they are affected by this drug. Taken together, these data suggest that our cardiomyocytes are a good and reliable tool for cardiac research and drug screening. Our future direction is to develop a platform with iPS-derived cardiomyocytes is to create a score of cardiotoxicity based and combined evaluation of different cardiotoxicity assays. We also established an efficient keratinocyte differentiation protocol. To date, we obtained 90% of K14-positive cells. iPS-derived keratinocytes expressed some keratinocyte markers as K14, K5, ITGa6, ITGb4, deltaNp63. After 7 days, exposed to a high concentration of calcium medium some cells expressed K10 and involucrin. Our future direction with iPS-derived keratinocytes is to evaluate their potential to grown in 3D model and evaluated their answers in cytotoxicity analyses.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Biotechnology & Biomaterials.
Editorial · 30 May 2025
3D Bioprinting of Vascularized Tissue Constructs Using Bioink-Embedded Endothelial Cells
Editorial · 30 May 2025
Development of Flexible Bioelectronic Interfaces for Real-Time Neural Signal Monitoring
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biotechnology & Biomaterials
- SubjectBiochemistry & Biotechnology
- SubjectMaterials Science
- BylineArticles whose byline prints “Estela M Cruvinel”